V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250001727 | 250008810 | 1.49 | 102.7 | null | null | 2016-11-24 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100760464 |
| 250001781 | 250008811 | 1.61 | 79.6 | null | null | 2019-03-30 | NIVOLUMAB | null | null | NIVOLUMAB | 100709188 |
| 250001786 | 250008812 | 1.72 | 92.9 | Palliative (P) | 2016-06-19 | 2016-07-07 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101079432 |
| 250001816 | 250008813 | 1.73 | 81.9 | null | null | 2021-12-01 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101042211 |
| 250001960 | 250008817 | 1.72 | 72.9 | null | 2020-12-14 | 2020-12-14 | null | 02 | null | NIVOLUMAB | 101408256 |
| 250001969 | 250008818 | 1.74 | 98.8 | null | null | 2017-06-13 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100580525 |
| 250002086 | 250008826 | 1.84 | 64.6 | null | null | 2020-09-12 | CARBOPLATIN + GEMCITABINE | null | null | CARBOPLATIN + GEMCITABINE | 101535464 |
| 250002113 | 250008829 | 0 | null | null | 2020-06-27 | 2020-07-16 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100126209 |
| 250002123 | 250008830 | 1.71 | 55.9 | Palliative (P) | 2018-07-29 | 2018-08-07 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101069749 |
| 250002154 | 250008834 | 1.88 | 80.6 | Palliative (P) | 2016-12-15 | 2017-02-07 | Bevacizumab 7.5mg/kg | 02 | N | CISPLATIN + RT | 100338236 |
| 250002156 | 250008835 | 1.16 | 99.8 | null | 2017-12-18 | 2018-01-01 | AXITINIB | 02 | null | CARBOPLATIN + PACLITAXEL | 100604334 |
| 250002186 | 250008838 | null | null | Palliative (P) | null | 2019-12-27 | null | null | N | GEMCARBO | 100759721 |
| 250002193 | 250008840 | 1.67 | 65 | null | 2019-01-13 | 2019-02-09 | Atezolizumab | 02 | N | ATEZOLIZUMAB | 100279828 |
| 250002223 | 250008842 | null | null | null | 2018-09-23 | 2018-09-25 | Carboplatin AUC 2 - 5 | 01 | null | CARBOPLATIN + FLUOROURACIL | 101307704 |
| 250002229 | 250008843 | null | null | null | null | 2020-01-11 | null | null | null | TRIAL UNSPECIFIED | 100945507 |
| 250002247 | 250008845 | 1.8 | 87.9 | Palliative (P) | 2020-11-13 | 2020-11-13 | Sunitinib | 02 | N | ENZALUTAMIDE | 100741886 |
| 250002251 | 250008847 | 1.68 | 53.6 | Palliative (P) | 2019-09-12 | 2019-09-12 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100520843 |
| 250002254 | 250008848 | null | null | null | null | 2020-08-23 | Trial Unspecified | null | N | NB HRNBL-1 COJEC IND COURSE C | 100575057 |
| 250002263 | 250008849 | null | null | null | 2018-03-09 | 2018-03-09 | DOXORUBICIN | 02 | N | STS RHABDO VIT0910 VINC IRINOTECAN | 100975579 |
| 250002272 | 250008850 | 1.79 | 65 | Palliative (P) | null | 2019-11-18 | BCG Intravesical | 02 | N | CARBOPLATIN | 100196390 |
| 250002279 | 250008852 | 1.78 | 67.45 | Curative (C) | null | 2020-04-27 | null | null | null | CABOZANTINIB | 101420799 |
| 250002286 | 250008854 | 0 | 59.1 | Palliative (P) | null | 2018-12-16 | NB HRNBL-1 Isotretinoin | 02 | N | NOT MATCHED | 100551826 |
| 250002309 | 250008857 | null | null | Palliative (P) | 2019-04-01 | 2019-04-09 | CETUXIMAB | 01 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101720961 |
| 250002313 | 250008858 | 1.85 | 79 | null | 2019-05-28 | 2019-06-12 | Doxorubicin + Olaratumab | 02 | N | CISPLATIN | 101535452 |
| 250002319 | 250008859 | 1.28 | 61.8 | Palliative (P) | 2019-05-22 | 2019-06-06 | null | 02 | N | LIPOSOMAL DOXORUBICIN | 101205298 |
| 250002328 | 250008860 | 1.6 | 83.1 | Palliative (P) | 2016-12-18 | 2016-12-25 | null | null | N | DOCETAXEL | 101387472 |
| 250002334 | 250008862 | null | null | Palliative (P) | null | 2020-02-28 | EW EuroEwing 2012 Arm B VDC/IE | null | null | TRIAL UNSPECIFIED | 101637139 |
| 250002335 | 250008863 | null | 14.6 | Palliative (P) | 2018-06-24 | 2020-05-05 | Capecitabine | 02 | null | CISPLATIN | 100304734 |
| 250002352 | 250008867 | 0 | 99.4 | Palliative (P) | 2020-03-28 | 2020-04-03 | Trial Unspecified | 02 | N | CETUXIMAB | 100092336 |
| 250002381 | 250008870 | 1.65 | 89 | null | 2019-02-03 | 2019-02-03 | Carboplatin + Etoposide IV 3 day | 02 | N | ATEZOLIZUMAB | 101735266 |
| 250002399 | 250008873 | null | null | Palliative (P) | null | 2017-05-20 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | null | CISPLATIN + PEMETREXED | 100263626 |
| 250002405 | 250008874 | 1.13 | 49.6 | null | 2018-05-14 | 2018-11-15 | CISPLATIN + FLUOROURACIL | 02 | N | DOCETAXEL | 100133184 |
| 250002410 | 250008876 | 1.72 | 66.7 | Adjuvant (A) | 2020-05-25 | 2020-06-08 | Doxorubicin + Ifosfamide | 02 | N | ETOPOSIDE + IFOSFAMIDE | 101773111 |
| 250002412 | 250008877 | 0 | 24.9 | Neo-adjuvant (N) | 2018-11-14 | 2018-11-16 | null | 01 | null | TRIAL UNSPECIFIED | 101613599 |
| 250002430 | 250008880 | null | null | null | null | 2019-10-21 | Capecitabine | null | null | MITOMYCIN INTRAVESICULAR | 100584231 |
| 250002434 | 250008881 | 1.7 | 64.5 | Palliative (P) | 2020-01-16 | 2020-01-27 | NB HRNBL-1 COJEC Ind COURSE B | N | N | ERLOTINIB | 101792055 |
| 250002460 | 250008883 | null | null | null | null | 2021-12-09 | Docetaxel | null | N | IMATINIB | 100235580 |
| 250002472 | 250008884 | 1.8 | 88 | Curative (C) | 2022-01-08 | 2022-04-26 | Carboplatin + Pemetrexed | 02 | null | CETUXIMAB + CISPLATIN + FLUOROURACIL | 100498184 |
| 250002487 | 250008885 | null | null | null | null | 2018-02-15 | Trial Unspecified | null | N | CARBOPLATIN + PACLITAXEL | 100660762 |
| 250002493 | 250008886 | 1.01 | 71.4 | Neo-adjuvant (N) | null | 2019-12-29 | null | null | Y | CETUXIMAB | 100390503 |
| 250002496 | 250008887 | null | null | null | null | 2021-08-06 | null | null | N | DOCETAXEL | 101022174 |
| 250002502 | 250008888 | 1.6 | 53.6 | Palliative (P) | 2021-03-08 | 2021-03-30 | null | 02 | null | GEMCARBO | 100633098 |
| 250002505 | 250008890 | null | null | Palliative (P) | null | 2020-04-26 | null | null | N | EW EUROEWING 2012 ARM B IE | 100572530 |
| 250002529 | 250008895 | 1.72 | 88 | null | 2019-12-17 | 2019-12-21 | null | null | N | CARBOPLATIN + VINORELBINE | 100323076 |
| 250002533 | 250008897 | 1.74 | 49 | null | 2019-03-20 | 2019-03-20 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | PACLITAXEL | 101026923 |
| 250002537 | 250008898 | 1.74 | 68.9 | null | 2020-01-18 | 2020-01-26 | IPILIMUMAB + NIVOLUMAB | 02 | null | AVELUMAB + AXITINIB | 100221084 |
| 250002541 | 250008899 | null | null | Palliative (P) | 2020-03-19 | 2020-03-21 | null | 02 | null | TRIAL UNSPECIFIED | 100870402 |
| 250000284 | 250008900 | 1.53 | 87.1 | Curative (C) | 2019-12-14 | 2019-12-22 | Cisplatin + Doxorubicin | 02 | null | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 101298839 |
| 250000744 | 250008903 | 1.56 | 0 | null | 2022-01-06 | 2022-01-09 | EVEROLIMUS | 02 | null | IMATINIB | 101856875 |
| 250000769 | 250008904 | 1.83 | 64 | null | 2021-12-08 | 2022-01-18 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | CISPLATIN | 101062710 |